PB2335: TRIAL IN PROGRESS: PHASE 3 TRIAL EVALUATING THE EFFICACY AND SAFETY OF ODRONEXTAMAB PLUS CHOP (O-CHOP) VERSUS R-CHOP IN PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA (OLYMPIA-3)

• Benoit Tessoulin,
• Stephanie Guidez,
• Manjusha Namuduri,
• Ashish Risal3,
• Alpana Waldron,
• Nickolas A. Sophos,
• Amulya Uppala,
• Min Zhu,
• Siobhán Nolan,
• Jurriaan Brouwer-Visser,
• Aafia Chaudhry,
• Srikanth Ambati,
• Hesham Mohamed,
• David Tucker

Affiliations

Benoit Tessoulin

1 Nantes University Hospital, Hematology Department, Nantes, France

Stephanie Guidez

2 Centre Hospitalier Universitaire (CHU) de Poitiers, Poitiers, France

Manjusha Namuduri

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Ashish Risal3

1 Nantes University Hospital, Hematology Department, Nantes, France

Alpana Waldron

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Nickolas A. Sophos

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Amulya Uppala

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Min Zhu

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Siobhán Nolan

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Jurriaan Brouwer-Visser

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Aafia Chaudhry

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Srikanth Ambati

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

Hesham Mohamed

3 Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States

David Tucker

4 Royal Cornwall Hospital, Cornwall, United Kingdom